Galenika announces the distribution of products from the aesthetic medicine segment
12/05/2024 • Customer news
The pharmaceutical company Galenika continues its strategic portfolio expansion, this time through a partnership with the Austrian company Croma-Pharma, which operates in worldwide markets and is one of the leading European producers of premium hyaluronic acid-based products, an important ingredient for skincare.
With this, Galenika is launching the distribution of seven new products in the aesthetic medicine segment for the markets of Serbia and Bosnia and Herzegovina. Croma-Pharma operates in 80 markets worldwide and adheres to the highest quality standards, which is the main prerequisite for this partnership.
The entire news article can be read at the following link.